Sébastien Faure Selected Research

Sébastien Faure Research Topics

Disease

8	Neoplasms (Cancer) 01/2019 - 11/2010
5	Carcinogenesis 01/2019 - 11/2010
3	Hypertension (High Blood Pressure) 02/2020 - 09/2011
3	Inflammation (Inflammations) 12/2017 - 06/2007
2	Infections 03/2022 - 06/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2011
2	Ischemia 04/2017 - 01/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015 - 01/2011
2	Hyperaldosteronism (Conn Syndrome) 01/2012 - 04/2006
1	COVID-19 03/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2022
1	Hyperventilation 03/2022
1	Asthma (Bronchial Asthma) 03/2022
1	Urinary Tract Infections (Urinary Tract Infection) 06/2021
1	Pain (Aches) 11/2018
1	Breakthrough Pain 11/2018
1	Cancer Pain 11/2018
1	Obesity 12/2017
1	Genomic Instability 10/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2013
1	Isolated Systolic Hypertension 01/2012
1	Essential Hypertension 09/2011
1	Fibrosarcoma 11/2010
1	Carcinoma (Carcinomatosis) 11/2010
1	Diabetes Mellitus 02/2010
1	Stroke (Strokes) 09/2009
1	Brain Ischemia (Cerebral Ischemia) 09/2009
1	Hypokalemia 04/2006

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020 - 06/2007
2	PolyphenolsIBA 02/2020 - 01/2012
2	Chlordecone (Kepone)IBA 01/2018 - 12/2012
2	delphinidinIBA 01/2018 - 04/2011
2	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 04/2017
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2017 - 03/2011
2	ethoxidineIBA 04/2017 - 03/2011
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2015 - 04/2011
2	Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric 10/2013 - 12/2012
2	AldosteroneIBA 01/2012 - 04/2006
1	COVID-19 VaccinesIBA 03/2022
1	VaccinesIBA 03/2022
1	ChlorineIBA 03/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2021
1	Estrogen ReceptorsIBA 02/2020
1	ChalconesIBA 02/2020
1	Opioid Analgesics (Opioids)IBA 11/2018
1	Morphine (MS Contin)FDA LinkGeneric 11/2018
1	Anthocyanins (Anthocyanin)IBA 01/2018
1	LipidsIBA 12/2017
1	benzo(c)phenanthridineIBA 04/2017
1	DEET (DET)IBA 01/2016
1	CytosineIBA 10/2014
1	EnzymesIBA 10/2014
1	MethyltransferasesIBA 10/2014
1	des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2012
1	3-nitrotyrosineIBA 01/2012
1	SaltsIBA 01/2012
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2012
1	Superoxides (Superoxide)IBA 01/2012
1	AnionsIBA 01/2012
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2012
1	Lysine (L-Lysine)FDA Link 09/2011
1	PhytochemicalsIBA 04/2011
1	FlavonoidsIBA 04/2011
1	GenisteinIBA 04/2011
1	ApigeninIBA 04/2011
1	PhenanthridinesIBA 03/2011
1	CamptothecinIBA 03/2011
1	Fas Ligand Protein (Fas Ligand)IBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	MethylcholanthreneIBA 11/2010
1	Type 2 Angiotensin ReceptorIBA 11/2010
1	3- mercapto- 3,3- cyclopentamethylenepropionic acidIBA 11/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2010
1	Angiotensin IIIBA 09/2009
1	Antihypertensive Agents (Antihypertensives)IBA 09/2009
1	Telmisartan (Micardis)FDA Link 09/2009
1	Vasoconstrictor AgentsIBA 06/2007
1	ReninIBA 04/2006

Therapy/Procedure

2	Therapeutics 06/2021 - 01/2019
1	Endurance Training 03/2022